Education and Resources

Navigate directly to what you need. This page contains applications for financial assistance, downloadable information about secondary hyperparathyroidism and Rayaldee® (calcifediol) extended-release capsules, and links to other helpful websites.

  Financial

PDF image of form

Patient assistance program application for Rayaldee® (calcifediol) extended-release capsules

PDF image of form

Solicitud para el programa de asistencia al paciente para Rayaldee® (calcifediol) extended-release capsules (solicitud en español)

PDF image of form

患者援助项目(PAP) 申请RAYALDEE®骨化二醇(CALCIFEDIOL) 缓释30毫克胶囊

  Education

Ready to learn more?

PDF image of brochure

Download the brochure for Rayaldee.

PDF image of brochure

Descargue el folleto para Rayaldee en español.

PDF image of brochure

Download information on how to stay on track with your Rayaldee treatment.

PDF image of brochure

Descargue información sobre cómo mantener el curso de tu tratamiento con Rayaldee.

PDF image of brochure

Download an infographic about understanding your CKD, SHPT and vitamin D lab work.

PDF image of handout

Download information from the National Kidney Foundation about how kidney disease can lead to bone and heart disease.

PDF image of handout

Download information from the National Kidney Foundation about how kidney disease can lead to bone and heart disease. This information sheet includes a place to write in the levels of calcium, phosphorus, parathyroid hormone, and vitamin D.

PDF image of quiz

Click here for information and a quiz about the risk for bone disease due to chronic kidney disease.

  Helpful Websites

Internet icon.

The American Association of Kidney Patients provides education, advocacy, and patient engagement for people with kidney disease and their families.

Internet icon.

The National Kidney Foundation offers support for all people affected by kidney disease through education, advocacy, and resources.

Important Safety Information

Before starting Rayaldee, the level of calcium in your blood should be in the normal range (below 9.8 mg/dL). Your doctor can tell you if your calcium level is right for starting Rayaldee.

Rayaldee can cause hypercalcemia and hypercalciuria (high levels of calcium in your blood and urine, respectively). You should tell your doctor if you are taking any other medications, including other vitamin D medications (prescription or over-the-counter vitamin D supplements). Your doctor may tell you to stop taking them while you are taking Rayaldee, as very high calcium levels due to high vitamin D levels could cause severe changes to your heart rhythm or seizures and require emergency treatment.

Tell your doctor about any and all medication you may be taking. While you are taking Rayaldee, tell your doctor if you receive any new prescriptions or start any new over-the-counter medications.

Tell your doctor immediately if you experience any of the following symptoms of very high calcium: feeling tired, difficulty thinking clearly, loss of appetite, nausea, vomiting, constipation, increased thirst, increased urination, weight loss, or any other abnormal symptoms or side effects.

While you are taking Rayaldee, your doctor will order laboratory tests to see how your SHPT is doing. These lab tests will also examine your blood levels of calcium, phosphorus, 25-hydroxyvitamin D, and PTH. Based on your test results, your dose of Rayaldee may be changed or stopped until your lab results improve.

The most common side effects of Rayaldee reported by patients in clinical trials were anemia (low levels of red blood cells or hemoglobin), infection in the nose and/or throat, high levels of blood creatinine (a lab test for measuring kidney function), shortness of breath, cough, congestive heart failure, and constipation. 

Take your Rayaldee at bedtime and swallow your capsules whole; do not bite or chew them.

If you miss a dose, take Rayaldee at your next scheduled time. Do not take an extra dose to make up for the dose you missed.

Be sure to follow your doctor’s orders, including getting your laboratory tests done on time.

1.

If you have questions regarding why you were prescribed Rayaldee, please speak with your doctor.

2.

If you have questions regarding Rayaldee or the disease state it is designated to treat, you may contact a Rayaldee Clinical Pharmacist at OPKO Connect at 1-844-414-OPKO (1-844-414-6756), option 1.

3.

If you have questions regarding the support programs offered by OPKO Connect, you can call 1-844-414-OPKO (1-844-414-6756), option 2.

4.

You are encouraged to report negative side effects to the U.S. Food and Drug Administration (FDA) at www.fda.gov/medwatch or via phone at 1-800-FDA-1088 (1-800-332-1088).

5.

For more information about Rayaldee, please contact OPKO Medical Information at 1-844-729-2539 or medicalinformation@opko.com.

Please see Full Prescribing Information.

Indication and Limitations of Use

Rayaldee is a treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and low vitamin D levels (25-hydroxyvitamin D less than 30 ng/mL). It is not for patients with stage 5 CKD or end-stage kidney disease on dialysis.

Important Safety Information

Before starting Rayaldee, the level of calcium in your blood should be in the normal range (below 9.8 mg/dL). Your doctor can tell you if your calcium level is right for starting Rayaldee.

Rayaldee can cause hypercalcemia and hypercalciuria (high levels of calcium in your blood and urine, respectively). You should tell your doctor if you are taking any other medications, including other vitamin D medications (prescription or over-the-counter vitamin D supplements). Your doctor may tell you to stop taking them while you are taking Rayaldee, as very high calcium levels due to high vitamin D levels could cause severe changes to your heart rhythm or seizures and require emergency treatment.

Tell your doctor about any and all medication you may be taking. While you are taking Rayaldee, tell your doctor if you receive any new prescriptions or start any new over-the-counter medications.

Tell your doctor immediately if you experience any of the following symptoms of very high calcium: feeling tired, difficulty thinking clearly, loss of appetite, nausea, vomiting, constipation, increased thirst, increased urination, weight loss, or any other abnormal symptoms or side effects.

While you are taking Rayaldee, your doctor will order laboratory tests to see how your SHPT is doing. These lab tests will also examine your blood levels of calcium, phosphorus, 25-hydroxyvitamin D, and PTH. Based on your test results, your dose of Rayaldee may be changed or stopped until your lab results improve.

The most common side effects of Rayaldee reported by patients in clinical trials were anemia (low levels of red blood cells or hemoglobin), infection in the nose and/or throat, high levels of blood creatinine (a lab test for measuring kidney function), shortness of breath, cough, congestive heart failure, and constipation. 

Take your Rayaldee at bedtime and swallow your capsules whole; do not bite or chew them.

If you miss a dose, take Rayaldee at your next scheduled time. Do not take an extra dose to make up for the dose you missed.

Be sure to follow your doctor’s orders, including getting your laboratory tests done on time.

1.

If you have questions regarding why you were prescribed Rayaldee, please speak with your doctor.

2.

If you have questions regarding Rayaldee or the disease state it is designated to treat, you may contact a Rayaldee Clinical Pharmacist at OPKO Connect at 1-844-414-OPKO (1-844-414-6756), option 1.

3.

If you have questions regarding the support programs offered by OPKO Connect, you can call 1-844-414-OPKO (1-844-414-6756), option 2.

4.

You are encouraged to report negative side effects to the U.S. Food and Drug Administration (FDA) at www.fda.gov/medwatch or via phone at 1-800-FDA-1088 (1-800-332-1088).

5.

For more information about Rayaldee, please contact OPKO Medical Information at 1-844-729-2539 or medicalinformation@opko.com.

Please see Full Prescribing Information.